Market Overview

Cannabis Deals And M&A Picking Up Steam Again

Cannabis Deals And M&A Picking Up Steam Again

The Viridian Cannabis Deal Tracker is an information service that monitors capital raise and M&A activity in the legal cannabis industry. Analyzing within 12 key industry sectors, the Viridian Cannabis Deal Tracker provides cannabis companies, investors, and acquirers with the data, trends, and intelligence they need to make informed decisions regarding deal valuations, terms, and structures. Since its inception, the Viridian Cannabis Deal Tracker has tracked and analyzed more than 2,400 capital raises totaling over $29 billion as well as more than 800 M&A transactions. Find it exclusively on Benzinga Cannabis every week!



•    Sixteen raises closed this past week, totaling nearly $267 million and outpacing the 12 deals totaling just over $73 million from the same week last year. While there were more deals closed this week compared to the prior-year period, the significantly greater aggregate capital raised led to an average deal size more than two and a half times greater ($16.1 million vs. $6.1 million). While we have seen some weakness in the cannabis capital markets in 2019, these large raise amounts point to continued investor interest in the sector.

•    Of the sixteen raises, eleven used equity structures. However, again this week, the largest raise closed used a debt structure. We continue to see the largest operators, particularly those in the Cultivation & Retail sector with large asset bases, able to raise large sums by issuing debt.

•    This week, the sixteen capital raise transactions were split evenly between "touching the plant" and ancillary businesses, pointing to continued broad capital markets activity in the cannabis industry.


•    We tracked six closed M&A transactions this past week, a count far fewer than the ten closed this week last year.

•    All of the closed transactions, aside from the reverse takeover, involved private companies as the targets. This week, however, not all the buyers were public as we have seen in prior periods.

•    We continue to see acquisitions of non-cannabis-related businesses by those in the cannabis sector. This week, an infused products company, Bhang, bought a non-cannabis organic nutritional beverage business, Red Ace, and a European medical cannabis business, Cannaray, purchased a non-cannabis drug distributor and importer, Therismos. We expect to see more acquisitions like these as cannabis companies look to capture valuable assets, technologies, or synergies from outside of the industry.

•    United States operators continue to utilize reverse takeovers to list on Canadian public exchanges. We expect this to persist until the U.S.-domiciled exchanges change their stance on listing companies with U.S. cannabis operations, a shift that may require a change in U.S. federal policy before being effectuated.

Related Story: Institutional Investors, From Credit Suisse To Citigroup, Helped Fund Cannabis Companies Last Month






Capital Raises by Week

Capital Raises by Sector



M&A Activity by Week

M&A Activity by Sector

Photo by Javier Hasse.

The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

Posted-In: Cannabis Deals Cannabis M&A Harrison PhillipsCannabis News Financing Markets General Best of Benzinga


Related Articles (ACB + CNBS)

View Comments and Join the Discussion!

Cannabis Movers

Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!

MenaPay Digitizing Cash In The Middle East, North Africa

Investors Take A Bite Out Of Chewy's Stock, But The Street Isn't Saying 'Good Boy!'